Return On Assets of ROCKET PHARMACEUTICALS, INC. from 30 Sep 2015 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
ROCKET PHARMACEUTICALS, INC. quarterly and annual Return On Assets in % history and change rate from 30 Sep 2015 to 30 Sep 2025.
  • ROCKET PHARMACEUTICALS, INC. Return On Assets for the quarter ending 30 Sep 2025 was -54%, a 0.48% increase year-over-year.
  • ROCKET PHARMACEUTICALS, INC. annual Return On Assets for 2024 was -55%, a 21% decline from 2023.
  • ROCKET PHARMACEUTICALS, INC. annual Return On Assets for 2023 was -46%, a 3.8% increase from 2022.
  • ROCKET PHARMACEUTICALS, INC. annual Return On Assets for 2022 was -48%, a 51% decline from 2021.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Change (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Change (%)

ROCKET PHARMACEUTICALS, INC. Quarterly Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -54% +0.26% +0.48% 01 Jul 2025 30 Sep 2025
Q2 2025 -57% -8.8% -18% 01 Apr 2025 30 Jun 2025
Q1 2025 -56% -9.2% -20% 01 Jan 2025 31 Mar 2025
Q4 2024 -55% -9.6% -21% 01 Oct 2024 31 Dec 2024
Q3 2024 -54% -6.6% -14% 01 Jul 2024 30 Sep 2024
Q2 2024 -48% +3.1% +6.1% 01 Apr 2024 30 Jun 2024
Q1 2024 -47% +2.6% +5.3% 01 Jan 2024 31 Mar 2024
Q4 2023 -46% +1.8% +3.8% 01 Oct 2023 31 Dec 2023
Q3 2023 -48% -3.4% -7.6% 01 Jul 2023 30 Sep 2023
Q2 2023 -51% -11% -28% 01 Apr 2023 30 Jun 2023
Q1 2023 -50% -16% -46% 01 Jan 2023 31 Mar 2023
Q4 2022 -48% -16% -51% 01 Oct 2022 31 Dec 2022
Q3 2022 -44% -11% -33% 01 Jul 2022 30 Sep 2022
Q2 2022 -40% -7.6% -24% 01 Apr 2022 30 Jun 2022
Q1 2022 -34% -0.54% -1.6% 01 Jan 2022 31 Mar 2022
Q4 2021 -32% +2.2% +6.5% 01 Oct 2021 31 Dec 2021
Q3 2021 -33% -5.8% -21% 01 Jul 2021 30 Sep 2021
Q2 2021 -32% -6.9% -27% 01 Apr 2021 30 Jun 2021
Q1 2021 -33% -9.1% -37% 01 Jan 2021 31 Mar 2021
Q4 2020 -34% -8.6% -34% 01 Oct 2020 31 Dec 2020
Q3 2020 -28% +3.2% +11% 01 Jul 2020 30 Sep 2020
Q2 2020 -25% +7.3% +22% 01 Apr 2020 30 Jun 2020
Q1 2020 -24% +11% +31% 01 Jan 2020 31 Mar 2020
Q4 2019 -25% +9% +26% 01 Oct 2019 31 Dec 2019
Q3 2019 -31% +2.9% +8.6% 01 Jul 2019 30 Sep 2019
Q2 2019 -33% -0.33% -1% 01 Apr 2019 30 Jun 2019
Q1 2019 -35% -6.6% -23% 01 Jan 2019 31 Mar 2019
Q4 2018 -34% -12% -55% 01 Oct 2018 31 Dec 2018
Q3 2018 -34% -42% -516% 01 Jul 2018 30 Sep 2018
Q2 2018 -32% -36% -911% 01 Apr 2018 30 Jun 2018
Q1 2018 -28% -28% -18760% 01 Jan 2018 31 Mar 2018
Q4 2017 -22% -16% -246% 01 Oct 2017 31 Dec 2017
Q3 2017 8.1% +41% 01 Jul 2017 30 Sep 2017
Q2 2017 4% +80% 01 Apr 2017 30 Jun 2017
Q1 2017 -0.15% +79% +100% 01 Jan 2017 31 Mar 2017
Q4 2016 -6.4% +73% +92% 01 Oct 2016 31 Dec 2016
Q3 2016 -33% +73% +69% 01 Jul 2016 30 Sep 2016
Q2 2016 -76% 01 Apr 2016 30 Jun 2016
Q1 2016 -79% 01 Jan 2016 31 Mar 2016
Q4 2015 -80% 01 Oct 2015 31 Dec 2015
Q3 2015 -106% 01 Jul 2015 30 Sep 2015

ROCKET PHARMACEUTICALS, INC. Annual Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
2024 -55% -9.6% -21% 01 Jan 2024 31 Dec 2024
2023 -46% +1.8% +3.8% 01 Jan 2023 31 Dec 2023
2022 -48% -16% -51% 01 Jan 2022 31 Dec 2022
2021 -32% +2.2% +6.5% 01 Jan 2021 31 Dec 2021
2020 -34% -8.6% -34% 01 Jan 2020 31 Dec 2020
2019 -25% +9% +26% 01 Jan 2019 31 Dec 2019
2018 -34% -12% -55% 01 Jan 2018 31 Dec 2018
2017 -22% -16% -246% 01 Jan 2017 31 Dec 2017
2016 -6.4% +73% +92% 01 Jan 2016 31 Dec 2016
2015 -80% 01 Jan 2015 31 Dec 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.